Mechanism and role of selective autophagy in ethanol-induced liver injury

选择性自噬在乙醇性肝损伤中的机制及作用

基本信息

  • 批准号:
    8509479
  • 负责人:
  • 金额:
    $ 18.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-06-15 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Alcoholic liver disease (ALD) is characterized by steatosis, inflammation and fibrosis, which can lead to end stage cirrhosis and multiple complications. Ethanol has very broad biological effects affecting multiple cellular processes. While significant progresses have been made regarding the understanding of the pathogenesis of ethanol induced liver injury, much has yet to be learnt about the cellular defense against the detrimental effects of ethanol. We recently find that macroautophagy is induced by acute ethanol treatment and has significant protective effects against ethanol-induced apoptosis and liver injury. Macroautophagy is an evolutionarily conserved intracellular degradation mechanism involved in diverse biological activities and in the pathogenesis of many diseases. It would thus be important to understand how and why macroautophagy can counteract the toxicity of ethanol in the liver, which could lead to a further understanding of the pathogenesis of ALD, and, more importantly, novel approaches to treat the disease. We have found that ethanol-induced autophagy is characterized by its selectivity toward damaged mitochondria and lipid droplets, but not general proteins. We thus hypothesize that this feature must be related to how autophagy affects ethanol-induced toxicity. Aim 1 of this project will investigate the mechanisms involved in the recognition of the damaged mitochondria and lipid droplets by the autophagosome in the ethanol conditions, and the dynamics of autophagy during a prolonged ethanol treatment to determine whether and how the function of autophagy may change during this course, thus providing important information for forge a possible therapeutic strategy to enhancing autophagy function. Aim 2 of this project will examine the hypothesis that autophagy reduces ethanol-induced cell death and liver injury by removing damaged mitochondria and reducing total cellular lipid content, culminating in decreased ROS generation, lipid peroxidation, and ER stress. We anticipate that this study will result in important and systemic findings of how autophagy may function in ethanol-induced pathogenesis. The subject of whether and how autophagy may affect the progression of ALD is novel, critical, but insufficiently studied, despite the wide recognition of the importance of both the disease (ALD) and the mechanism (autophagy in the liver). This project could thus yield important information for the development of a novel approach toward the treatment of ALD.
描述(由申请人提供):酒精性肝病(ALD)以脂肪变性、炎症和纤维化为特征,可导致终末期肝硬化和多种并发症。乙醇具有非常广泛的生物效应,影响多种细胞过程。虽然对乙醇诱导肝损伤的发病机制的理解已经取得了重大进展,但对细胞防御乙醇有害影响的了解还很多。我们最近发现急性乙醇处理可诱导巨噬,并对乙醇诱导的细胞凋亡和肝损伤具有显著的保护作用。巨噬是一种进化保守的细胞内降解机制,参与多种生物活性和许多疾病的发病机制。因此,了解巨噬如何以及为什么可以抵消肝脏中乙醇的毒性是很重要的,这可能会导致进一步了解ALD的发病机制,更重要的是,治疗这种疾病的新方法。我们发现乙醇诱导的自噬的特点是其对受损线粒体和脂滴的选择性,而不是对一般蛋白质的选择性。因此,我们假设这一特征一定与自噬如何影响乙醇诱导的毒性有关。本项目目的1将研究乙醇条件下自噬体对受损线粒体和脂滴的识别机制,以及长时间乙醇处理过程中自噬的动态变化,以确定自噬功能在此过程中是否以及如何发生变化,从而为制定可能的治疗策略提供重要信息,以增强自噬功能。该项目的目标2将检验自噬通过去除受损线粒体和降低细胞总脂质含量,最终减少ROS生成,脂质过氧化,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

XIAO-MING YIN其他文献

XIAO-MING YIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('XIAO-MING YIN', 18)}}的其他基金

The Role of HMGB1 in autophagy deficiency-induced liver pathology
HMGB1 在自噬缺陷引起的肝脏病理中的作用
  • 批准号:
    10188516
  • 财政年份:
    2018
  • 资助金额:
    $ 18.37万
  • 项目类别:
The Role of HMGB1 in autophagy deficiency-induced liver pathology
HMGB1 在自噬缺陷引起的肝脏病理中的作用
  • 批准号:
    10137441
  • 财政年份:
    2018
  • 资助金额:
    $ 18.37万
  • 项目类别:
The Role of HMGB1 in autophagy deficiency-induced liver pathology
HMGB1 在自噬缺陷引起的肝脏病理中的作用
  • 批准号:
    9751288
  • 财政年份:
    2018
  • 资助金额:
    $ 18.37万
  • 项目类别:
Mechanism and role of selective autophagy in ethanol-induced liver injury
选择性自噬在乙醇性肝损伤中的机制及作用
  • 批准号:
    8867956
  • 财政年份:
    2014
  • 资助金额:
    $ 18.37万
  • 项目类别:
High-Content Cell-Based Screening for Modulators of Autophagy
基于高内涵细胞的自噬调节剂筛选
  • 批准号:
    7453976
  • 财政年份:
    2007
  • 资助金额:
    $ 18.37万
  • 项目类别:
The impact of growth modulation of liver carcinogenesis
生长调节对肝癌发生的影响
  • 批准号:
    8237696
  • 财政年份:
    2005
  • 资助金额:
    $ 18.37万
  • 项目类别:
The impact of growth modulation of liver carcinogenesis
生长调节对肝癌发生的影响
  • 批准号:
    7261321
  • 财政年份:
    2005
  • 资助金额:
    $ 18.37万
  • 项目类别:
The impact of growth modulation of liver carcinogenesis
生长调节对肝癌发生的影响
  • 批准号:
    7430459
  • 财政年份:
    2005
  • 资助金额:
    $ 18.37万
  • 项目类别:
The impact of growth modulation of liver carcinogenesis
生长调节对肝癌发生的影响
  • 批准号:
    7081233
  • 财政年份:
    2005
  • 资助金额:
    $ 18.37万
  • 项目类别:
The impact of growth modulation of liver carcinogenesis
生长调节对肝癌发生的影响
  • 批准号:
    7627384
  • 财政年份:
    2005
  • 资助金额:
    $ 18.37万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 18.37万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了